Newly identified events in the RE-LY trial

N Engl J Med. 2010 Nov 4;363(19):1875-6. doi: 10.1056/NEJMc1007378.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anticoagulants / adverse effects*
  • Atrial Fibrillation / drug therapy*
  • Benzimidazoles / adverse effects*
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / epidemiology
  • Dabigatran
  • Embolism / chemically induced
  • Hemorrhage / chemically induced
  • Humans
  • Myocardial Infarction / chemically induced
  • Myocardial Infarction / epidemiology
  • Pyridines / adverse effects*

Substances

  • Anticoagulants
  • Benzimidazoles
  • Pyridines
  • Dabigatran